BIONIK LABORATORIES CORP. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 71 rows, 71 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2022-10-25: Reporting owner Gonsalves Daniel; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
- 2022-10-25: Reporting owner Gonsalves Daniel; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
- 2022-10-06: Reporting owner Russo Richard Paul Jr; Form 4; Security Employee Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2021-10-14: Reporting owner Wass Loren W.; Form 4; Security Employee Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2022-10-25 holding as of filing | Gonsalves Daniel Officer (Executive Vice President & CFO) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $2.10 exercise price | 2022-10-25 | ||
| 2022-10-25 holding as of filing | Gonsalves Daniel Officer (Executive Vice President & CFO) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $0.30 exercise price | 2022-10-25 | ||
| 2022-10-06 | Russo Richard Paul Jr Officer (CEO and President) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +60,000 60,000 owned after | $0.30 exercise price | 2022-10-13 | |
| 2021-10-14 | Wass Loren W. Officer (See Remarks) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +55,000 55,000 owned after | $2.10 exercise price | 2021-10-18 | |
| 2021-10-14 | Russo Richard Paul Jr Officer (CFO and Interim CEO) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +80,000 80,000 owned after | $2.10 exercise price | 2021-10-15 | |
| 2021-07-15 | AUBERTON-HERVE ANDRE-JACQUES Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −51,878 63,881 owned after | $3.60 exercise price | 2022-06-21 | |
| 2021-07-15 | AUBERTON-HERVE ANDRE-JACQUES Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,500 0 owned after | $3.16 exercise price | 2022-06-21 | |
| 2021-07-15 | Gaston-Dreyfus Remi Director, 10% Owner | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −115,759 0 owned after | $3.60 exercise price | 2021-12-13 | |
| 2021-07-15 | Gaston-Dreyfus Remi Director, 10% Owner | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 0 owned after | $3.16 exercise price | 2021-12-13 | |
| 2020-12-01 holding as of filing | Russo Richard Paul Jr Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $1.21 exercise price | 2020-12-01 | ||
| 2019-09-12 holding as of filing | Wass Loren W. Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.20 exercise price | 2019-09-12 | ||
| 2019-07-26 | AUBERTON-HERVE ANDRE-JACQUES Director | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +115,759 115,759 owned after | $3.59 exercise price | 2019-08-08 | |
| 2019-07-26 | Dusseux Eric Michel Director, Officer (Chief Executive Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +115,759 115,759 owned after | $3.59 exercise price | 2019-07-30 | |
| 2019-07-26 | Gaston-Dreyfus Remi Director | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +115,759 115,759 owned after | $3.59 exercise price | 2019-07-30 | |
| 2019-07-26 | MARTIN JOSEPH R Director | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +19,293 19,293 owned after | $3.59 exercise price | 2019-07-30 | |
| 2019-07-26 | Matine Charles Director | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +19,293 19,293 owned after | $3.59 exercise price | 2019-07-30 | |
| 2019-07-26 | Thevenon Audrey Director | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +19,293 19,293 owned after | $3.59 exercise price | 2019-07-30 | |
| 2019-07-26 | MALONE PETER GERALD Director | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +19,293 19,293 owned after | $3.59 exercise price | 2019-07-30 | |
| 2019-05-31 | AUBERTON-HERVE ANDRE-JACQUES | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $3.16 exercise price | 2019-06-04 | |
| 2019-05-31 | Thevenon Audrey Director | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $3.16 exercise price | 2019-06-04 | |
| 2019-05-31 | Gaston-Dreyfus Remi Director | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $3.16 exercise price | 2019-06-04 | |
| 2019-05-31 | MARTIN JOSEPH R Director | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $3.16 exercise price | 2019-06-04 | |
| 2019-05-31 | MALONE PETER GERALD Director | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $3.16 exercise price | 2019-06-04 | |
| 2019-05-31 | Dusseux Eric Michel Director, Officer (Chief Executive Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +110,855 110,855 owned after | $3.16 exercise price | 2019-06-04 | |
| 2019-05-31 | Matine Charles Director | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $3.16 exercise price | 2019-06-04 | |
| 2019-05-31 | MARKOW LESLIE NADENE Officer (Chief Financial Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,400 7,400 owned after | $3.16 exercise price | 2019-06-04 | |
| 2018-06-26 holding as of filing | Maloberti Renaud Bertrand Officer (Chief Commercial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $0.05 exercise price | 2018-06-26 | ||
| 2018-06-15 holding as of filing | AUBERTON-HERVE ANDRE-JACQUES Director | 3/A | Stock Option (Right to Buy) Derivative · Indirect · Shares held through 4A Consulting and Engineering | Holding | $0.16 exercise price | 2018-06-15 | ||
| 2018-05-29 holding as of filing | AUBERTON-HERVE ANDRE-JACQUES Director | 3 | Stock Option (Right to Buy) Derivative · Indirect · Shares held through 4A Consulting and Engineering | Holding | $0.68 exercise price | 2018-05-29 | ||
| 2018-05-29 holding as of filing | AUBERTON-HERVE ANDRE-JACQUES Director | 3 | Stock Option (Right to Buy) Derivative · Indirect · Shares held through 4A Consulting and Engineering | Holding | $0.16 exercise price | 2018-05-29 | ||
| 2018-04-20 | Dusseux Eric Michel Director, Officer (Chief Executive Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000,000 6,000,000 owned after | $0.06 exercise price | 2018-04-24 | |
| 2018-01-24 | Dusseux Eric Michel Director, Officer (Chief Executive Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +500,000 500,000 owned after | $0.16 exercise price | 2018-01-26 | |
| 2018-01-24 | PRYWATA MICHAL Director, Officer (Chief Technology Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +500,000 500,000 owned after | $0.16 exercise price | 2018-01-26 | |
| 2018-01-24 | MARKOW LESLIE NADENE Officer (Chief Financial Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +300,000 300,000 owned after | $0.16 exercise price | 2018-01-26 | |
| 2018-01-24 | McCarthy Timothy A. Officer (See Remarks) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $0.16 exercise price | 2018-01-26 | |
| 2017-09-11 holding as of filing | Gaston-Dreyfus Remi Director | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $1.00 exercise price | 2017-09-11 | ||
| 2017-09-01 | Dusseux Eric Michel Director, Officer (Chief Executive Officer) | 4/A | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,122,677 6,122,677 owned after | $0.16 exercise price | 2017-10-05 | |
| 2017-09-01 | Dusseux Eric Michel Director, Officer (Chief Executive Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,107,677 6,107,677 owned after | $0.16 exercise price | 2017-09-15 | |
| 2017-08-03 | McCarthy Timothy A. Officer (Chief Commercialization Office) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,500,000 1,500,000 owned after | $0.21 exercise price | 2017-08-24 | |
| 2017-08-03 | McCarthy Timothy A. Officer (Chief Commercialization Office) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +250,000 250,000 owned after | $0.21 exercise price | 2017-08-24 | |
| 2017-08-03 | McCarthy Timothy A. Officer (Chief Commercialization Office) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +250,000 250,000 owned after | $0.21 exercise price | 2017-08-24 | |
| 2016-09-23 holding as of filing | McCarthy Timothy A. McCarthy Officer (Chief CommercializationOfficer) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $1.00 exercise price | 2016-09-23 | ||
| 2016-04-28 holding as of filing | Fried Jules Marc Officer (VP - U.S. Operations) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $0.95 exercise price | 2016-04-28 | ||
| 2016-04-28 holding as of filing | Fried Jules Marc Officer (VP - U.S. Operations) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $0.25 exercise price | 2016-04-28 | ||
| 2016-04-28 holding as of filing | Fried Jules Marc Officer (VP - U.S. Operations) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $1.05 exercise price | 2016-04-28 | ||
| 2016-04-28 holding as of filing | Fried Jules Marc Officer (VP - U.S. Operations) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $0.95 exercise price | 2016-04-28 | ||
| 2016-04-28 holding as of filing | Fried Jules Marc Officer (VP - U.S. Operations) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $0.95 exercise price | 2016-04-28 | ||
| 2016-04-28 holding as of filing | Fried Jules Marc Officer (VP - U.S. Operations) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $0.25 exercise price | 2016-04-28 | ||
| 2016-04-28 holding as of filing | Fried Jules Marc Officer (VP - U.S. Operations) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $1.05 exercise price | 2016-04-28 | ||
| 2016-04-28 holding as of filing | Fried Jules Marc Officer (VP - U.S. Operations) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $0.95 exercise price | 2016-04-28 | ||
| 2016-04-28 holding as of filing | Krebs Hermano Igo Officer (Chief Science Officer) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $0.95 exercise price | 2016-04-28 | ||
| 2016-04-28 holding as of filing | Krebs Hermano Igo Officer (Chief Science Officer) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $0.95 exercise price | 2016-04-28 | ||
| 2016-04-28 holding as of filing | Krebs Hermano Igo Officer (Chief Science Officer) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $1.05 exercise price | 2016-04-28 | ||
| 2016-04-28 holding as of filing | Krebs Hermano Igo Officer (Chief Science Officer) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $1.05 exercise price | 2016-04-28 | ||
| 2016-04-28 holding as of filing | Krebs Hermano Igo Officer (Chief Science Officer) | 3 | Employee Stock Option (Right to Buy) Derivative · Indirect · (m) | Holding | $0.95 exercise price | 2016-04-28 | ||
| 2016-04-28 holding as of filing | Krebs Hermano Igo Officer (Chief Science Officer) | 3 | Employee Stock Option (Right to Buy) Derivative · Indirect · (m) | Holding | $1.05 exercise price | 2016-04-28 | ||
| 2016-04-28 holding as of filing | Krebs Hermano Igo Officer (Chief Science Officer) | 3 | Employee Stock Option (RIght to Buy) Derivative · Indirect · (m) | Holding | $0.95 exercise price | 2016-04-28 | ||
| 2016-04-28 holding as of filing | Krebs Hermano Igo Officer (Chief Science Officer) | 3 | Employee Stock Option (Right to Buy) Derivative · Indirect · (m) | Holding | $1.05 exercise price | 2016-04-28 | ||
| 2015-12-14 | PRYWATA MICHAL Director, Officer (Chief Operating Officer), 10% Owner | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +400,000 400,000 owned after | $1.00 exercise price | 2015-12-16 | |
| 2015-12-14 | MATHIEU MARC Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $1.00 exercise price | 2015-12-16 | |
| 2015-12-14 | Hariri Robert J Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $1.00 exercise price | 2015-12-16 | |
| 2015-12-14 | Bloch Peter D. Director, Officer (Chairman and CEO) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,000,000 1,000,000 owned after | $1.00 exercise price | 2015-12-16 | |
| 2015-11-27 | MARKOW LESLIE NADENE Officer (Chief Financial Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +400,000 400,000 owned after | $1.22 exercise price | 2015-12-01 | |
| 2015-06-30 holding as of filing | PRYWATA MICHAL Director, Officer (Chief Operating Officer), 10% Owner | 3/A | Stock Option (Option to Buy) Derivative · Direct | Holding | $0.23 exercise price | 2015-06-30 | ||
| 2015-06-30 holding as of filing | CAIRES THIAGO MORAIS ULHOA Director, Officer (Chief Technology Officer), 10% Owner | 3/A | Stock Option (Option to Buy) Derivative · Direct | Holding | $0.23 exercise price | 2015-06-30 | ||
| 2015-06-30 holding as of filing | Bloch Peter D. Director, Officer (Chief Executive Officer) | 3/A | Stock Option (Option to Buy) Derivative · Direct | Holding | $0.23 exercise price | 2015-06-30 | ||
| 2015-03-30 holding as of filing | Hariri Robert J Director | 3 | Stock Option (Option to Buy) Derivative · Direct | Holding | $0.23 exercise price | 2015-03-30 | ||
| 2015-03-09 holding as of filing | MARKOW LESLIE NADENE Officer (Chief Financial Officer) | 3 | Stock Option (Option to Buy) Derivative · Direct | Holding | $0.23 exercise price | 2015-03-09 | ||
| 2015-03-09 holding as of filing | Bloch Peter D. Director, Officer (Chief Executive Officer) | 3 | Stock Option (Option to Buy) Derivative · Direct | Holding | $0.23 exercise price | 2015-03-09 | ||
| 2015-03-09 holding as of filing | CAIRES THIAGO MORAIS ULHOA Officer (See Remarks) | 3 | Stock Option (Option to Buy) Derivative · Direct | Holding | $0.23 exercise price | 2015-03-09 | ||
| 2015-03-09 holding as of filing | PRYWATA MICHAL Director, Officer (Chief Operating Officer) | 3 | Stock Option (Option to Buy) Derivative · Direct | Holding | $0.23 exercise price | 2015-03-09 |